Alnylam Leaps As A New Approval Prepares Its Upcoming Conflict With BridgeBio And Pfizer
Friday saw a spike in Alnylam's shares after the pharmaceutical company received a second FDA clearance for Amvuttra. Amvuttra was…
Friday saw a spike in Alnylam's shares after the pharmaceutical company received a second FDA clearance for Amvuttra. Amvuttra was…
Please make advantage of the sharing resources accessible through the article's side or top share button. It is against FT.com's…
According to the firm, Optum Rx, which comprises the pharmacy benefit manager of the healthcare giant UnitedHealth Group, is removing…
The US central bank cautioned that President Donald Trump's tariffs were "clearly" driving up prices, therefore it lowered its growth…
In keeping with tradition, Nvidia CEO Jensen Huang's keynote address at the company's GTC 2025 conference on Tuesday was jam-packed…
Google (GOOGL)-2.34%) on Tuesday announced that it has signed a definitive agreement to acquire Israeli cybersecurity startup Wiz for $32…
Following the company's $713 million IPO on the Nasdaq, which priced significantly above the anticipated range, Astera Labs' shares ended…
Celestial AI, a business focused on optical interconnectivity, raised $250 million in a Series C1 financing headed by Fidelity Management…